Soluble CD23 controls IgE synthesis and homeostasis in human B cells

Journal of Immunology

Volumn 188, Issue 7, 2012, Pages 3199-3207

  Cooper, Alison M ^a,b   Hobson, Philip S ^a,b   Jutton, Mark R ^b,d   Kao, Michael W ^a,b   Drung, Binia ^c   Schmidt, Boris ^c   Fear, David J ^a   Beavil, Andrew J ^a,b   McDonnell, James M ^a,b   Sutton, Brian J ^a,b   Gould, Hannah J ^a,b  

^a GUY S HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c DARMSTADT UNIVERSITY OF TECHNOLOGY   (Germany)

^d Sudler and Hennessey   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM10 ENDOPEPTIDASE; ANTIBODY; CD23 ANTIGEN; CD40 ANTIBODY; COMPLEMENT COMPONENT C3D RECEPTOR; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN E; INTERLEUKIN 4; RECOMBINANT ANTIGEN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANTIGEN BINDING; ARTICLE; B LYMPHOCYTE; BIOACCUMULATION; CONTROLLED STUDY; FEEDBACK SYSTEM; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN SECRETION; PROTEIN SYNTHESIS INHIBITION; UPREGULATION;

ADAM PROTEINS; AMYLOID PRECURSOR PROTEIN SECRETASES; B-LYMPHOCYTES; DIPEPTIDES; FEEDBACK, PHYSIOLOGICAL; GENE EXPRESSION REGULATION; GENES, IMMUNOGLOBULIN; HOMEOSTASIS; HUMANS; HYDROXAMIC ACIDS; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOGLOBULIN E; IMMUNOLOGIC CAPPING; MEMBRANE PROTEINS; PROTEASE INHIBITORS; PROTEIN BINDING; RECEPTORS, COMPLEMENT 3D; RECEPTORS, IGE; RECOMBINANT FUSION PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SOLUBILITY; UP-REGULATION;

EID: 84859374924     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102689     Document Type: Article

References (51)

1. Spiegelberg, H. L. 1991. Fc epsilon R2/CD23: its discovery and possible functions. Monogr. Allergy 29: 1-8.
2. Gould, H. J., and B. J. Sutton. 2008. IgE in allergy and asthma today. Nat. Rev. Immunol. 8: 205-217. (Pubitemid 351323292)
3. Beavil, R. L., P. Graber, N. Aubonney, J. Y. Bonnefoy, and H. J. Gould. 1995. CD23/Fc epsilon RII and its soluble fragments can form oligomers on the cell surface and in solution. Immunology 84: 202-206.
4. Beavil, A. J., R. L. Edmeades, H. J. Gould, and B. J. Sutton. 1992. Alpha-helical coiled-coil stalks in the low-affinity receptor for IgE (Fc epsilon RII/CD23) and related C-type lectins. Proc. Natl. Acad. Sci. USA 89: 753-757.
5. Yokota, A., H. Kikutani, T. Tanaka, R. Sato, E. L. Barsumian, M. Suemura, and T. Kishimoto. 1988. Two species of human Fc epsilon receptor II (Fc epsilon RII/CD23): tissue-specific and IL-4-specific regulation of gene expression. Cell 55: 611-618.
6. Lorenzo, G. D., P. Mansueto, M. Melluso, G. Morici, D. Cigna, G. Candore, and C. Caruso. 1996. Serum levels of total IgE and soluble CD23 in bronchial asthma. Mediators Inflamm. 5: 43-46. (Pubitemid 26109929)
7. Di Lorenzo, G., A. Drago, M. E. Pellitteri, G. Candore, A. Colombo, M. Potestio, A. Di Salvo, S. Mansueto, and C. Caruso. 1999. Serum levels of soluble CD23 in patients with asthma or rhinitis monosensitive to Parietaria. Its relation to total serum IgE levels and eosinophil cationic protein during and out of the pollen season. Allergy Asthma Proc. 20: 119-125.
8. Yanagihara, Y., M. Sarfati, D. Marsh, T. Nutman, and G. Delespesse. 1990. Serum levels of IgE-binding factor (soluble CD23) in diseases associated with elevated IgE. Clin. Exp. Allergy 20: 395-401. (Pubitemid 20208477)
9. McCloskey, N., J. Hunt, R. L. Beavil, M. R. Jutton, G. J. Grundy, E. Girardi, S. M. Fabiane, D. J. Fear, D. H. Conrad, B. J. Sutton, and H. J. Gould. 2007. Soluble CD23 monomers inhibit and oligomers stimulate IGE synthesis in human B cells. J. Biol. Chem. 282: 24083-24091. (Pubitemid 47328009)
10. Rosenwasser, L. J., W. W. Busse, R. G. Lizambri, T. A. Olejnik, and M. C. Totoritis. 2003. Allergic asthma and an anti-CD23 mAb (IDEC-152): results of a phase I, single-dose, dose-escalating clinical trial. J. Allergy Clin. Immunol. 112: 563-570.
11. Rosenwasser, L. J., and J. Meng. 2005. Anti-CD23. Clin. Rev. Allergy Immunol. 29: 61-72. (Pubitemid 41434104)
12. Cho, S. W., M. A. Kilmon, E. J. Studer, H. van der Putten, and D. H. Conrad. 1997. B cell activation and Ig, especially IgE, production is inhibited by high CD23 levels in vivo and in vitro. Cell. Immunol. 180: 36-46.
13. Yu, P., M. Kosco-Vilbois, M. Richards, G. Köhler, and M. C. Lamers. 1994. Negative feedback regulation of IgE synthesis by murine CD23. Nature 369: 753-756. (Pubitemid 24225366)
14. Nakamura, T., W. S. Kloetzer, P. Brams, K. Hariharan, S. Chamat, X. Cao, M. J. LaBarre, P. C. Chinn, R. A. Morena, W. S. Shestowsky, et al. 2000. In vitro IgE inhibition in B cells by anti-CD23 monoclonal antibodies is functionally dependent on the immunoglobulin Fc domain. Int. J. Immunopharmacol. 22: 131-141. (Pubitemid 30102274)
15. Sherr, E., E. Macy, H. Kimata, M. Gilly, and A. Saxon. 1989. Binding the low affinity Fc epsilon R on B cells suppresses ongoing human IgE synthesis. J. Immunol. 142: 481-489. (Pubitemid 19039965)
16. Conrad, D. H., J. W. Ford, J. L. Sturgill, and D. R. Gibb. 2007. CD23: an overlooked regulator of allergic disease. Curr. Allergy Asthma Rep. 7: 331-337. (Pubitemid 47377321)
17. Lemieux, G. A., F. Blumenkron, N. Yeung, P. Zhou, J.Williams, A. C. Grammer, R. Petrovich, P. E. Lipsky, M. L. Moss, and Z. Werb. 2007. The low affinity IgE receptor (CD23) is cleaved by the metalloproteinase ADAM10. J. Biol. Chem. 282: 14836-14844. (Pubitemid 47093331)
18. Weskamp, G., J. W. Ford, J. Sturgill, S. Martin, A. J. Docherty, S. Swendeman, N. Broadway, D. Hartmann, P. Saftig, S. Umland, et al. 2006. ADAM10 is a principal 'sheddase' of the low-affinity immunoglobulin E receptor CD23. Nat. Immunol. 7: 1293-1298. (Pubitemid 46111250)
19. Mathews, J. A., J. Ford, S. Norton, D. Kang, A. Dellinger, D. R. Gibb, A. Q. Ford, H. Massay, C. L. Kepley, P. Scherle, et al. 2011. A potential new target for asthma therapy: a disintegrin and metalloprotease 10 (ADAM10) involvement in murine experimental asthma. Allergy 66: 1193-1200.
20. Gibb, D. R., M. El Shikh, D. J. Kang, W. J. Rowe, R. El Sayed, J. Cichy, H. Yagita, J. G. Tew, P. J. Dempsey, H. C. Crawford, and D. H. Conrad. 2010. ADAM10 is essential for Notch2-dependent marginal zone B cell development and CD23 cleavage in vivo. J. Exp. Med. 207: 623-635.
21. Gough, L., O. Schulz, H. F. Sewell, and F. Shakib. 1999. The cysteine protease activity of the major dust mite allergen Der p 1 selectively enhances the immunoglobulin E antibody response. J. Exp. Med. 190: 1897-1902.
22. Schulz, O., B. J. Sutton, R. L. Beavil, J. Shi, H. F. Sewell, H. J. Gould, P. Laing, and F. Shakib. 1997. Cleavage of the low-affinity receptor for human IgE (CD23) by a mite cysteine protease: nature of the cleaved fragment in relation to the structure and function of CD23. Eur. J. Immunol. 27: 584-588. (Pubitemid 27110568)
23. Mayer, R. J., B. J. Bolognese, N. Al-Mahdi, R. M. Cook, P. L. Flamberg, M. J. Hansbury, S. Khandekar, E. Appelbaum, A. Faller, and L. A. Marshall. 2000. Inhibition of CD23 processing correlates with inhibition of IL-4- stimulated IgE production in human PBL and hu-PBL-reconstituted SCID mice. Clin. Exp. Allergy 30: 719-727. (Pubitemid 30305636)
24. Aubry, J. P., S. Pochon, P. Graber, K. U. Jansen, and J. Y. Bonnefoy. 1992. CD21 is a ligand for CD23 and regulates IgE production. Nature 358: 505-507.
25. Delespesse, G., M. Sarfati, C. Y. Wu, S. Fournier, and M. Letellier. 1992. The low-affinity receptor for IgE. Immunol. Rev. 125: 77-97.
26. Bowles, S. L., C. Jaeger, C. Ferrara, J. Fingeroth, M. Van De Venter, and V. Oosthuizen. 2011. Comparative binding of soluble fragments (derCD23, sCD23, and exCD23) of recombinant human CD23 to CD21 (SCR 1-2) and native IgE, and their effect on IgE regulation. Cell. Immunol. 271: 371-378.
27. Bajorath, J., and A. Aruffo. 1996. Structure-based modeling of the ligand binding domain of the human cell surface receptor CD23 and comparison of two independently derived molecular models. Protein Sci. 5: 240-247. (Pubitemid 26054279)
28. Hermann, P., M. Armant, E. Brown, M. Rubio, H. Ishihara, D. Ulrich, R. G. Caspary, F. P. Lindberg, R. Armitage, C. Maliszewski, et al. 1999. The vitronectin receptor and its associated CD47 molecule mediates proinflammatory cytokine synthesis in human monocytes by interaction with soluble CD23. J. Cell Biol. 144: 767-775. (Pubitemid 29234554)
29. Hibbert, R. G., P. Teriete, G. J. Grundy, R. L. Beavil, R. Reljic, V. M. Holers, J. P. Hannan, B. J. Sutton, H. J. Gould, and J. M. McDonnell. 2005. The structure of human CD23 and its interactions with IgE and CD21. J. Exp. Med. 202: 751-760. (Pubitemid 41345964)
30. Aubry, J. P., S. Pochon, J. F. Gauchat, A. Nueda-Marin, V. M. Holers, P. Graber, C. Siegfried, and J. Y. Bonnefoy. 1994. CD23 interacts with a new functional extracytoplasmic domain involving N-linked oligosaccharides on CD21. J. Immunol. 152: 5806-5813.
31. Fearon, D. T., and R. H. Carter. 1995. The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. Annu. Rev. Immunol. 13: 127-149.
32. Cherukuri, A., P. C. Cheng, and S. K. Pierce. 2001. The role of the CD19/CD21 complex in B cell processing and presentation of complement-tagged antigens. J. Immunol. 167: 163-172. (Pubitemid 32567774)
33. Dierks, S. E., W. C. Bartlett, R. L. Edmeades, H. J. Gould, M. Rao, and D. H. Conrad. 1993. The oligomeric nature of the murine Fc epsilon RII/CD23. Implications for function. J. Immunol. 150: 2372-2382. (Pubitemid 23127483)
34. Texido, G., H. Eibel, G. Le Gros, and H. van der Putten. 1994. Transgene CD23 expression on lymphoid cells modulates IgE and IgG1 responses. J. Immunol. 153: 3028-3042. (Pubitemid 24292528)
35. Lamers, M. C., and P. Yu. 1995. Regulation of IgE synthesis. Lessons from the study of IgE transgenic and CD23-deficient mice. Immunol. Rev. 148: 71-95. (Pubitemid 26010543)
36. Frémeaux-Bacchi, V., E. Fischer, S. Lecoanet-Henchoz, J. C. Mani, J. Y. Bonnefoy, and M. D. Kazatchkine. 1998. Soluble CD21 (sCD21) forms biologically active complexes with CD23: sCD21 is present in normal plasma as a complex with trimeric CD23 and inhibits soluble CD23-induced IgE synthesis by B cells. Int. Immunol. 10: 1459-1466. (Pubitemid 28451440)
37. Henchoz, S., J. F. Gauchat, J. P. Aubry, P. Graber, S. Pochon, and J. Y. Bonnefoy. 1994. Stimulation of human IgE production by a subset of anti-CD21 monoclonal antibodies: requirement of a co-signal to modulate epsilon transcripts. Immunology 81: 285-290. (Pubitemid 24223207)
38. Hoettecke, N., A. Ludwig, S. Foro, and B. Schmidt. 2010. Improved synthesis of ADAM10 inhibitor GI254023X. Neurodegener. Dis. 7: 232-238.
39. Cheng, L. E., Z. E. Wang, and R. M. Locksley. 2010. Murine B cells regulate serum IgE levels in a CD23-dependent manner. J. Immunol. 185: 5040-5047.
40. Christie, G., A. Barton, B. Bolognese, D. R. Buckle, R. M. Cook, M. J. Hansbury, G. P. Harper, L. A. Marshall, M. E. McCord, K. Moulder, et al. 1997. IgE secretion is attenuated by an inhibitor of proteolytic processing of CD23 (Fc epsilonRII). Eur. J. Immunol. 27: 3228-3235. (Pubitemid 28018019)
41. Saxon, A., Z. Ke, L. Bahati, and R. H. Stevens. 1990. Soluble CD23 containing B cell supernatants induce IgE from peripheral blood B-lymphocytes and costimulate with interleukin-4 in induction of IgE. J. Allergy Clin. Immunol. 86: 333-344. (Pubitemid 20305636)
42. Sturgill, J. L., J. Mathews, P. Scherle, and D. H. Conrad. 2011. Glutamate signaling through the kainate receptor enhances human immunoglobulin production. J. Neuroimmunol. 233: 80-89.
43. Frémeaux-Bacchi, V., I. Bernard, F. Maillet, J. C. Mani, M. Fontaine, J. Y. Bonnefoy, M. D. Kazatchkine, and E. Fischer. 1996. Human lymphocytes shed a soluble form of CD21 (the C3dg/Epstein-Barr virus receptor, CR2) that binds iC3b and CD23. Eur. J. Immunol. 26: 1497-1503. (Pubitemid 26229994)
44. Hebell, T., J. M. Ahearn, and D. T. Fearon. 1991. Suppression of the immune response by a soluble complement receptor of B lymphocytes. Science 254: 102-105. (Pubitemid 21917326)
45. Roberts, T., and E. C. Snow. 1999. Cutting edge: recruitment of the CD19/CD21 coreceptor to B cell antigen receptor is required for antigen-mediated expression of Bcl-2 by resting and cycling hen egg lysozyme transgenic B cells. J. Immunol. 162: 4377-4380. (Pubitemid 29314831)
46. Reljić, R., G. Cosentino, and H. J. Gould. 1997. Function of CD23 in the response of human B cells to antigen. Eur. J. Immunol. 27: 572-575. (Pubitemid 27085266)
47. Achatz, G., L. Nitschke, and M. C. Lamers. 1997. Effect of transmembrane and cytoplasmic domains of IgE on the IgE response. Science 276: 409-411. (Pubitemid 27180701)
48. Venkitaraman, A. R., G. T. Williams, P. Dariavach, and M. S. Neuberger. 1991. The B-cell antigen receptor of the five immunoglobulin classes. Nature 352: 777-781. (Pubitemid 21912423)
49. Bohnsack, J. F., and N. R. Cooper. 1988. CR2 ligands modulate human B cell activation. J. Immunol. 141: 2569-2576. (Pubitemid 18263035)
50. Pierce, S. K. 2002. Lipid rafts and B-cell activation. Nat. Rev. Immunol. 2: 96-105. (Pubitemid 37323233)
51. Sarfati, M., and G. Delespesse. 1988. Possible role of human lymphocyte receptor for IgE (CD23) or its soluble fragments in the in vitro synthesis of human IgE. J. Immunol. 141: 2195-2199.